{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "S",
          "alt": "A",
          "position": "935"
        },
        "variant_string_id": "LRRK2 S935A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the cause of the most common inherited and some sporadic forms of Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism by linking LRRK2 mutations to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "LRRK2 variant levels were analyzed by Western blot analysis with the indicated antibodies and quantified using LI-COR and Odyssey system. The data was analyzed by One-way ANOVA (** P,0.01). Data are presented as mean value (6 SEM) from three independent experiments.",
          "judgment": "Yes",
          "reasoning": "The assays used (Western blot and immunoprecipitation) are standard techniques in the field and model the disease mechanism by assessing protein levels and interactions.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The data was analyzed by One-way ANOVA (** P,0.01). Data are presented as mean value (6 SEM) from three independent experiments.",
          "judgment": "Yes",
          "reasoning": "The paper mentions that experiments were performed in triplicate, indicating multiple replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": " FLAG-LRRK2-WT, S935A, R1",
          "judgment": "No",
          "reasoning": "The paper does not explicitly mention the use of known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The S935A variant in LRRK2 was analyzed using Western blot and immunoprecipitation assays, which are standard techniques in the field. The data showed significant differences (p < 0.01) and were replicated in three independent experiments. However, the lack of explicit variant controls means the evidence strength is supporting rather than moderate or very strong."
    }
  ]
}